Foghorn Therapeutics Inc.

FHTX ·Healthcare, Drug Manufacturers - General, United States
Balance Sheet Asset & Liabilities Breakdown

Asset & Liabilities Breakdown

Asset Breakdown FY2024

Total Assets: $284.0M

Liabilities Breakdown FY2024

Total Liabilities: $329.5M